… Belimumab was approved in Canada in 2011 and is indicated in addition to standard therapy
for reducing disease … Sandra Iczkovitz was an employee of GSK at the time of the study. …

… at baseline in this study was 51.3%, which is lower than what is typically reported in RCT
of SLE (> 65%) 12,13,14 . This discrepancy is likely a result of several patients in this study …

Objective. Persistent systemic lupus erythematosus (SLE) disease activity is associated with
increased morbidity and mortality. In a multicenter cohort of patients with prevalent SLE, we …

… Abstract: Real-world evidence for patients with advanced EGFR-mutated non-small cell lung
cancer (NSCLC) in Canada is limited. This study’s objective was to use previously validated …

Objective The treatment algorithm for new onset systemic lupus erythematosus (SLE) is less
well defined than for other rheumatic diseases. We examined the treatment patterns in an …

… A total of 1069 AEs were reported during the study period, of which 32 AE’s were reported
from Jan 2011 to Dec 2012. The average monthly reporting rates of AE’s, SAE’s and CAE’s …

… is important but I do not believe that it is novel. It seems that this proposition was in fact seized
upon by the House of Lords in 1873. As this is applicable in the law of wills so it is … there is …

… in both African and American Burkitt ‘s lymphoma. I9 In the … is higher than in the matched
controls, the titer is not as elevated as in the African type.lQ, 2o Most, but not all, African Burkitt’s …

Two cases of pyogenic sacroiliitis are reported and the literature reviewed. Gluteal pain,
tenderness in the sacroiliac area, and pain elicited by maneuvers which stress the joint are …

… the right solution to fill a mission need and if it is, that the system is acquired and deployed
the right way, meaning that it is done in a manner that maximizes the chances of delivering …